Telescope Innovations Corp. (CSE:TELI)
0.3500
-0.0100 (-2.78%)
Feb 9, 2026, 3:56 PM EST
Telescope Innovations Revenue
Telescope Innovations had revenue of 2.70M CAD in the quarter ending November 30, 2025, with 124.23% growth. This brings the company's revenue in the last twelve months to 6.28M, up 58.25% year-over-year. In the fiscal year ending August 31, 2025, Telescope Innovations had annual revenue of 4.78M with 12.03% growth.
Revenue (ttm)
6.28M
Revenue Growth
+58.25%
P/S Ratio
4.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 4.78M | 513.19K | 12.03% |
| Aug 31, 2024 | 4.27M | 1.44M | 51.07% |
| Aug 31, 2023 | 2.82M | 2.23M | 374.31% |
| Aug 31, 2022 | 595.40K | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Microbix Biosystems | 18.59M |
| Devonian Health Group | 18.52M |
| Rapid Dose Therapeutics | 2.78M |
| Britannia Life Sciences | 260.58K |
| MedMira | 232.99K |